z-logo
open-access-imgOpen Access
Advanced quantitative analysis of the sub-retinal pigment epithelial space in recurrent neovascular age-related macular degeneration
Author(s) -
Mariko Sasaki,
Y. Kato,
Kaoru Fujinami,
Toshiaki Hirakata,
Kazushige Tsunoda,
Kenji Watanabe,
Kunihiko Akiyama,
Tomoyuki Noda
Publication year - 2017
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0186955
Subject(s) - macular degeneration , ophthalmology , medicine , retinal , retinal pigment epithelium , optical coherence tomography
To quantitatively evaluate changes in the sub-retinal pigment epithelial (RPE) space and determine the association with recurrent neovascular age-related macular degeneration (AMD). Twenty-two eyes treated with intravitreal aflibercept for treatment-naïve neovascular AMD were studied retrospectively. The sub-RPE area, volume, and central retinal thickness (CRT) were evaluated 1 and 2 months after the loading phase using spectral-domain optical coherence tomography. Recurrence was defined as newly detected neovascular activity during the 6 months after the loading phase. In eyes with recurrent AMD, the sub-RPE area increased significantly ( P = 0.036) from 1 to 2 months after the loading phase and the sub-RPE volume increased marginally ( P = 0.06). Subgroup analysis showed significant ( P = 0.008 and P = 0.016, respectively) increases in the sub-RPE area and volume in typical AMD. In eyes with no recurrence, no significant changes occurred in the two parameters. No significant CRT changes occurred in eyes with or without a recurrence. A quantitative analysis demonstrated an increased likelihood of the sub-RPE space shortly after the loading phase in eyes with recurrent AMD; no changes occurred in eyes without a recurrence. These early changes in the sub-RPE space could indicate disease activity and are valuable for predicting recurrences of neovascular AMD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here